Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAn NIH grant/contract funding entry for 2017 was added, and the revision tag was updated from v3.6.5 to v3.6.6. This also implies the page’s version history has advanced and reflects the newer revision along with the added funding information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling a new build or patch of the site. This change does not alter the study details or the information presented on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now reflects a new revision identifier (v3.6.4), indicating a recent update to the site. The update does not modify the study details or user-facing information.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3, indicating a minor update or fix to the ClinicalTrials.gov page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page footer shows Revision: v3.6.2, replacing the previous v3.6.0, signaling a system version update rather than a change to the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' indicating enrollment closure. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision tag updated to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.